Order Article Reprints

Huynh Le Maux A, Pignol B, Behr-Roussel D, Blachon J-L, Chabrier P-E, Compagnie S, Picaut P, Bernabé J, Giuliano F, Denys P. Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport^®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity? Toxins. 2015; 7(12):5462-5471. https://doi.org/10.3390/toxins7124896

Huynh Le Maux, Amélie, Bernadette Pignol, Delphine Behr-Roussel, Jean-Luc Blachon, Pierre-Etienne Chabrier, Sandrine Compagnie, Philippe Picaut, Jacques Bernabé, François Giuliano, and Pierre Denys. 2015. "Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport^®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?" Toxins 7, no. 12: 5462-5471. https://doi.org/10.3390/toxins7124896

Huynh Le Maux, A., Pignol, B., Behr-Roussel, D., Blachon, J.-L., Chabrier, P.-E., Compagnie, S., Picaut, P., Bernabé, J., Giuliano, F., & Denys, P. (2015). Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport^®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity? Toxins, 7(12), 5462-5471. https://doi.org/10.3390/toxins7124896